Prognostic outcomes of diffuse large B-cell lymphoma patients with myelocytomatosis oncogene (MYC) and B-cell lymphoma 2 (BCL2) co-expression
2025; Springer Science+Business Media; Volume: 18; Issue: 1 Linguagem: Inglês
10.1007/s12308-025-00623-z
ISSN1868-9256
AutoresSupanut Kumjan, Kantang Satayasoontorn, Kasidid Lawongsa, Chonlada Laoruangroj,
Tópico(s)CNS Lymphoma Diagnosis and Treatment
Referência(s)